Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.4%

1 terminated/withdrawn out of 231 trials

Late-Stage Pipeline

54%

124 trials in Phase 3/4

Results Transparency

0 of 17 completed trials have results

Key Signals

92 recruiting

Enrollment reporting

Analytics

Phase 3

110(47.6%)

Phase 2

69(29.9%)

N/A

14(6.1%)

Phase 4

14(6.1%)

Phase 1/2

13(5.6%)

Phase 2/3

7(3.0%)

Phase 1

3(1.3%)

Early Phase 1

1(0.4%)

231Total

Phase 3(110)

Phase 2(69)

N/A(14)

Phase 4(14)

+4 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (231)

Showing 20 of 231 trials

NCT07880769Phase 2/3Not Yet Recruiting

Verapamil In Preclinical Type 1 Diabetes

Role: lead

NCT05681442Phase 4Active Not Recruiting

Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis

Role: lead

NCT05687500Phase 2Completed

Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)

Role: lead

NCT05030155Phase 3Completed

Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)

Role: lead

NCT06351475Not ApplicableRecruiting

Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Role: lead

NCT07842523Phase 2Not Yet Recruiting

Obinutuzumab in Systemic Sclerosis

Role: lead

NCT06833788Phase 4Recruiting

Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression

Role: lead

NCT07827742Phase 2Not Yet Recruiting

Rituximab vs Placebo for Maintenance in Systemic Sclerosis - Interstitial Lung Disease

Role: lead

NCT07486024Phase 3Recruiting

Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)

Role: lead

NCT07644377Phase 3Not Yet Recruiting

Discontinuation Versus Continuation of Riociguat Monotherapy in Chronic Thromboembolic Pulmonary Hypertension Successfully Treated With Balloon Pulmonary Angioplasty

Role: lead

NCT07812701Phase 2Not Yet Recruiting

Topical Clobetasol Propionate for Inflammatory Hand Osteoarthritis

Role: lead

NCT05153070Phase 2Recruiting

Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes

Role: lead

NCT05213104Phase 3Active Not Recruiting

Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia

Role: lead

NCT04031573Phase 3Completed

Ivabradine for Heart Rate Control In Septic Shock

Role: lead

NCT05545384Phase 3Recruiting

Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-MOG Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial

Role: lead

NCT05664191Phase 2Completed

Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage

Role: lead

NCT07268521Phase 2Recruiting

A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab

Role: lead

NCT06722118Phase 3Recruiting

Corticosteroids Before Extubation in Pediatric Intensive Care Unit

Role: lead

NCT05844462Phase 3Recruiting

Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease

Role: lead

NCT07120880Phase 3Recruiting

Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia

Role: lead